Key Segments:
By Product
-
Kits and Reagents
-
Instruments
By Technology
-
16S rRNA Sequencing
-
Shotgun Metagenomics
-
Metatranscriptomics
-
Other Technologies
By Sample
-
Fecal Samples
-
Saliva Samples
-
Skin Samples
-
Other Samples
By Application
-
Disease Diagnostics
-
Gastrointestinal Disorders
-
Metabolic Disorders
-
Other Disease Diagnostics
-
-
Research Applications
By End Use
-
Hospitals
-
Academic and Research Institutes
-
Pharmaceutical and Biotechnology Companies
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players in the Microbiome Diagnostics Market include Diversigen, Inc., Microba Life Sciences Limited, DayTwo, Inc., Viome Life Sciences, Inc., and CosmosID, Inc., among others.
Key opportunities in the Microbiome Diagnostics Market include advancements in microbiome sequencing, growing adoption of personalized medicine, and expanding applications in gastrointestinal disease diagnosis and precision healthcare.
The market is driven by increasing research into the human microbiome, rising prevalence of gastrointestinal disorders, and growing demand for personalized diagnostic and treatment approaches.
The Kits and Reagents segment dominated the Microbiome Diagnostics Market, accounting for approximately 65.00% market share.
The North America region dominated the Microbiome Diagnostics Market in 2025 with a 40.00% share, driven by advanced healthcare infrastructure and increasing adoption of microbiome testing.
